Factors associated with symptom distress in women with breast cancer prior to initiation of chemotherapy.
Factors associated with symptom distress in women with breast cancer prior to initiation of chemotherapy.
复制标题
DOI:
10.1016/j.apnr.2021.151515
复制
发表时间:
2021-12
期刊:
影响因子:
--
通讯作者:
Rosenzweig MQ
中科院分区:
文献类型:
--
作者:
Mazanec SR;Park S;Connolly MC;Rosenzweig MQ
Symptom distress in women with breast cancer is associated with early discontinuation of chemotherapy and may influence treatment outcomes. Describing racial differences in prechemotherapy symptom distress and examining contextual variables of the symptom experience may inform our understanding of the complex problem of racial disparities in breast cancer. To determine if perceived social support, healthcare system distrust, and economic hardship predict symptom distress in women with breast cancer prior to their first chemotherapy treatment. Descriptive, correlational, cross-sectional Baseline data (N = 119) was used from a multisite, longitudinal study comparing the symptom experience and ability to receive chemotherapy of Black and White women with breast cancer (R01MD012245;Rosenzweig, PI). Measures included the Symptom Distress Scale, Interpersonal Support Evaluation List, Health Care System Distrust Scale, and Psychological Sense of Economic Hardship scale. The analysis consisted of multiple regression and a t-test. On average, participants reported five symptoms prior to chemotherapy. Black women reported higher symptoms distress than White women; t(68.34) = 2.15, p = .035. The model explained 26% of variance in symptom distress; F(5, 112) = 9.01, p < .001. While controlling for age and race, greater perceived economic hardship contributed to higher symptom distress (β = .36, p = .001, 95% CI: .34 to 1.34). Race, health care system distrust and social support did not significantly predict symptom distress. Assessment of perceived financial hardship prior to beginning chemotherapy is critical to identify those patients at risk for greater symptom distress.
登录
查看更多内容
DOI:
10.1002/onco.13822
发表时间:
2021-09
期刊:
The oncologist
影响因子:
--
作者:
Nielson CM;Bylsma LC;Fryzek JP;Saad HA;Crawford J
通讯作者:
Crawford J
影响因子:
4.2
作者:
Denieffe, Suzanne;Cowman, Seamus;Gooney, Martina
通讯作者:
Gooney, Martina
影响因子:
13.8
作者:
Hu X;Chehal PK;Kaplan C;Krukowski RA;Lan RH;Stepanski E;Schwartzberg L;Vidal G;Graetz I
通讯作者:
Graetz I
影响因子:
3.2
作者:
Lyon ME;Cheng YI;Needle J;Friebert S;Baker JN;Jiang J;Wang J
通讯作者:
Wang J
影响因子:
3.1
作者:
Barrera, M;Caples, H;Tein, JY
通讯作者:
Tein, JY